Alpha Paradigm Partners, LLC Horizon Therapeutics Public LTD CO Transaction History

Alpha Paradigm Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $1.04 Million - $1.49 Million	-17,617 Reduced 78.9%	4,710 $292,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.2 Million - $1.75 Million	15,066 Added 207.49%	22,327 $1.78 Billion
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $338,593 - $430,235	-3,918 Reduced 35.05%	7,261 $764 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $389,016 - $473,284	3,947 Added 54.58%	11,179 $1.21 Billion
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $329,037 - $395,124	3,580 Added 98.03%	7,232 $792 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $817,209 - $1.09 Million	-11,377 Reduced 75.7%	3,652 $336,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $1.01 Million - $1.27 Million	15,029 New	15,029 $1.1 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.